First Page | Document Content | |
---|---|---|
![]() Date: 2015-05-04 08:54:02Iron metabolism Hepcidin Human iron metabolism Ferroportin Transferrin Iron deficiency Anemia of chronic disease Iron overload Hephaestin Ferritin Acute-phase protein Iron metabolism disorder | Add to Reading List |
![]() | THE METABOLISM OF IRON IRON IO IONS Oral supply 5-25% availabilityDocID: 1ptV5 - View Document |
![]() | Turning Spiegelmers into Drugs NOXXON Pharma is a biopharmaceutical company pioneering the development of a new class of proprietary therapeutics called Spiegelmers*, the chemically synthesized, immunologically passive aDocID: 1a5Tb - View Document |
![]() | PRESS RELEASE First Data from NOXXON’s NOX-H94 (Lexaptepid Pegol) Clinical Trial in ESA-Hyporesponsive Dialysis Patients Reported at ERA-EDTA Conference Berlin, Germany and Boston, USA - May 29, NOXXON Pharma aDocID: 19ryN - View Document |
![]() | PDF DocumentDocID: 191Vu - View Document |
![]() | LEAD Action News vol 9 no 3 Short Part 1DocID: 183Zb - View Document |